Article

  • Uploaded by: Sajeev Ram
  • 0
  • 0
  • December 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Article as PDF for free.

More details

  • Words: 392
  • Pages: 1
Advertiser profiles BD Medical– Pharmaceutical Systems 1 Becton Dr. Franklin Lakes, NJ 07417 tel. 800.225.3310 fax 201.847.4847 [email protected] www.bd.com/pharmaceuticals

Description BD Medical–Pharmaceutical Systems is dedicated to developing prefillable drug-delivery systems designed to fit the needs of the pharmaceutical industry. BD offers a range of products, including glass and plastic prefillable syringes, a nasal-spray system, and various self-injection devices. Each of these differentiates pharmaceutical products and contributes to the optimization of drug therapy. All the company’s prefillable devices are designed to meet healthcare professionals’ demands for safety and convenience and to fulfill patients’ needs for comfort. BD’s worldwide presence, market awareness, and pharmaceutical packaging know-how allow the company to propose suitable solutions for all regional markets and parenteral drug-delivery needs. AAPS Booth 1443

Ben Venue Laboratories

BENEO-Palatinit GmbH

PO Box 46568 Bedford, OH 44146 tel. 440.232.3320 fax 440.439.6398 peter.hansbury@ boehringer-ingelheim.com www.benvenue.com

Gottlieb-Daimler-Strasse 12 68165 Mannheim, Germany tel. +49 621 421 150 fax +49 621 421 160 [email protected] www.galeniq.com

Description Ben Venue Laboratories develops and manufactures sterile liquid and lyophilized products under contract. The company has expertise in handling complex formulations and has contributed to the creation of many significant pharmaceutical products for nearly 70 years. Products from Ben Venue Laboratories are distributed globally. Ben Venue Laboratories is a wholly owned subsidiary of Boehringer Ingelheim Corporation.

Description BENEO-Palatinit is a 100% subsidiary of Südzucker AG. As a member of IPEC, BENEO-Palatinit is implementing under IPEC–GMP conditions for bulk pharmaceutical excipients. BENEO-Palatinit is showing its multifunctional sugarfree excipient galenIQ. Based on hydrogenated isomaltulose and its refined modifications, galenIQ is offered in different grades for solid dosage forms.

Products and services • Dedicated cytotoxic and genotoxic manufacturing facility opening Q2 2009 • Phase I to commercial on-site production in batch sizes from 1 L to 2000 L • Liquid or lyophilized sterile products • Centrally located 500,000-ft2 manufacturing facility • Largest contract sterileinjectable lyophilization capacity in the world • Expertise in manufacturing complex formulations—microspheres, liposomes, emulsions, and nanotechnology • Global product distribution.

Products and services galenIQ from BENEO-Palatinit is a range of bulk excipients, including tailor-made grades for oral solid dosage forms. Excellent alternatives for direct compression, capsule-filling, or powder-mixture applications present galenIQ grades 720 and 721. The galenIQ 800 series additionally offers special powder grades for wet granulation, compaction, and other agglomeration processes. AAPS Booth 504

AAPS Booth 1949 130

Pharmaceutical Technology  NOVEMBER 2008

pharmtech.com

Related Documents

Article
October 2019 27
Article
November 2019 11
Article
October 2019 56
Article
November 2019 20
Article
October 2019 19
Article
October 2019 21

More Documents from ""

Article
December 2019 32
Ems Action Plan
April 2020 27
Background 3
December 2019 35
Ela
December 2019 43
Lipos
December 2019 33
Plan Basic
December 2019 39